Matrixx Launches Zicam Products To Rebound During Cold Season

Matrixx Initiatives says after weathering the storm of recalling two Zicam OTC homeopathic intranasal zinc-containing cold products, the firm's "real test" will come when the cold season reveals whether customers switch to oral delivery products

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet